Business
DoorDash sticker on door
(Michael M. Santiago/Getty Images)

DoorDash took $80 billion in orders and subscriptions in 2024, but still operated at a loss

What’s eating all the profits?

Tom Jones, David Crowther

Much of the discourse around “private burrito taxi” economics, which crops up every six months when people get really bored on Twitter, suggests that the companies bringing us our expensive (but convenient) goods must be making a fortune from our everything-now appetites. In DoorDash’s case, though, profit has proved tricky to deliver.

In the last quarter alone, DoorDash took almost $21.3 billion in subscription fees and deliveries — from essentials picked at the local grocery store to booze and take-out burgers — bringing its gross order value for the year to ~$80.2 billion.

After the restaurants, shops, and drivers took their share of the total order figure, DoorDash posted some $10.7 billion in revenues in 2024, but still operated at a $38 million loss through the year. Even in Q4 specifically, when the company did turn an operating profit, it was pretty miniscule, at just over 4% of revenues. All of this begs the question: who, or what, is devouring DoorDash’s profits?

DoorDash Economics
Sherwood News

Big bites

Sales & Marketing was one of DoorDash’s biggest outlays in 2024, at more than $2 billion for the year and some $541 million in Q4 (those 30-second Super Bowl ad slots don’t come cheap), while the company also racked up ~$100 million Research & Development spend each month as it upped efforts to increase the range of stuff you can get directly to your door. 

While the bottom line understandably remains a key concern for DoorDash investors, with total operating losses in the region of $3.25 billion over the last five years, the absence of enormous profits isn’t hurting the stock this morning — shares are up about 2% in early trading, thanks to its better-than-expected Q4.

Interestingly, DoorDash delivery drivers who worked the Super Bowl shift earned over $50 million across the US this year, with Philly-based Dashers alone taking $390,000, per data shared with Axios.

More Business

See all Business
The Sphere In Las Vegas

Washington D.C. looks set to get America’s second Sphere

Revenue for the Las Vegas version of the big orb has soared, but the sphere is still a money pit.

business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.